Cardinal Health
CAH NYSE· Health Care Distributors
Last close · Oct 26, 2026
$251.54
KIRA · Stoqly’s AI analyst, in plain words
- Cardinal Health had $254.2B of revenue in fiscal 2026, up 14.2% on the year before. Over five years, revenue changed +9.4% a year on average.
- Its operating margin was 1.0%, up 0.0 pts: of every 100 in sales, about 1 is left after running the business.
- Cardinal Health made $1.7B of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 6.7% a year.
- Free cash flow was $4.5B in fiscal 2026, 1.8% of revenue.
- Cardinal Health returned $1.8B to shareholders in fiscal 2026, 41% of free cash flow. The diluted share count fell 2.1%.
- Cardinal Health owes $4.0B more than it holds in cash, about 1.1 years of operating profit.
Market cap
$59.6B
P/E
—
Revenue
$254.2B
Net income
$1.7B
Free cash flow
$4.5B
Operating margin
1.0%
Cardinal Health in 30 seconds · fiscal 2026
Are sales growing?
+14.2%
Yes. Sales grew 14.2% last year.
Does it make a profit?
0.7%
A little. It keeps 0.7% of every sale as profit.
Does profit turn into cash?
1.8%
Partly. 1.8% of sales ends up as free cash.
Is debt under control?
1.1x
Keep an eye on it. Repaying its debt would take 1.1 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
What Cardinal Health does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 11, 2026
- Legal name
- Cardinal Health, Inc.
- CIK
- 0000721371
Cardinal Health · CAH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $181.3B | $205.0B | $226.8B | $222.6B | $254.2B |
| Revenue growth | 11.6% | 13.0% | 10.7% | −1.9% | 14.2% |
| Gross margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
| Operating margin | −0.3% | 0.4% | 0.6% | 1.0% | 1.0% |
| Net income | −$938M | $330M | $852M | $1.6B | $1.7B |
| Net margin | −0.5% | 0.2% | 0.4% | 0.7% | 0.7% |
| Diluted EPS | −$3.37 | $1.26 | $3.45 | $6.45 | $7.23 |
| Cash | |||||
| Cash from operations | $3.2B | $2.8B | $3.8B | $2.4B | $5.2B |
| Capital expenditure | $387M | $481M | $511M | $547M | $649M |
| Free cash flow | $2.8B | $2.4B | $3.3B | $1.9B | $4.5B |
| FCF margin | 1.5% | 1.2% | 1.4% | 0.8% | 1.8% |
| Dividends paid | $559M | $525M | $499M | $494M | $491M |
| Share buybacks | $1.0B | $2.0B | $750M | $765M | $1.4B |
| Share count change | −5.1% | −6.1% | −5.7% | −2.0% | −2.1% |
| Debt and strength | |||||
| Cash and short-term investments | $4.7B | $4.1B | $5.3B | $3.9B | $4.9B |
| Debt incl. finance leases | $5.3B | $4.7B | $5.1B | $8.5B | $8.9B |
| Shareholders' equity | −$709M | −$3.0B | −$3.2B | −$2.8B | −$2.9B |
| Net debt / EBITDA | 7.0x | 0.4x | −0.1x | 1.5x | 1.1x |
| Current ratio | 1.1x | 1.0x | 1.0x | 0.9x | 0.9x |
| Interest coverage | −4.1x | 9.0x | 24.4x | 10.6x | 7.5x |
| Returns and quality | |||||
| Piotroski F-score | 5 | 7 | 6 | 6 | 6 |
| Altman Z'' | 0.2 | 0.0 | −0.0 | −0.0 | −0.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$61.6M
8 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cardinal Health · CAH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Cardinal Health CAH | $59.6B | 14.2% | 1.0% | 1.8% | — | — | 6 |
| Cencora COR | $64.0B | 9.3% | 0.8% | 1.0% | — | 24.5x | 7 |
| McKesson MCK | $118.4B | 12.4% | 1.5% | 1.4% | — | 26.6x | 6 |
| Henry Schein HSIC | $9.7B | 4.0% | 5.0% | 4.4% | 7.5% | 24.6x | 6 |
| Cigna CI | $80.7B | 11.2% | 3.4% | — | 11.7% | 12.6x | 7 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $251.54 a share, the company is worth $59.6B.
Cardinal Health grew sales faster than 4 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0000721371). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.